All News

Top news of the day from across the health care landscape

Experts are beginning to see that some phenotypes respond better to certain treatment approaches for asthma.

Phase 3 data show that ocrelizumab (Ocrevus) may delay the progression of disability, such as the need for a wheelchair, in patients with primary progressive multiple sclerosis (PPMS).

The updated label includes new evidence that the treatment significantly impedes the progression of joint structural damage at 24 weeks compared to placebo for patients with active psoriatic arthritis.

The label update includes new evidence that the treatment significantly impedes the progression of joint structural damage at 24 weeks compared to placebo for patients with active psoriatic arthritis.

Researchers were not able to predict factors that would indicate that pharmacists actually dispense the medication.

Quizartinib has prolonged survival in patients with a rare and deadly form of acute myeloid leukemia.

Motivational interviewing—a patient-centered method to enhance intrinsic motivation by exploring, and resolving ambivalence—has gained a good reputation for increasing adherence.

Researchers investigated whether high body mass index is a risk factor not only for a greater risk of multiple sclerosis, but also for advancing to the secondary progressive stage of the disease.

Even though patients with advanced chronic obstructive pulmonary disease (COPD) can suffer from the same distressing symptoms as those with end-stage cancer, they are less likely to receive palliative care than those with other terminal illnesses.

A form of artificial intelligence known as a deep learning convolutional neural network outperformed dermatologists in diagnosing malignant melanomas.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape

Researchers identified a promising biomarker for the PARP-inhibitor sensitivity in small cell lung cancer, which may help in determining the appropriate treatment for select patients.

Using gene editing to remove CD33, a protein targeted to treat acute myeloid leukemia with chimeric antigen receptor (CAR) T cells, from healthy stem cells could reduce toxicity experienced by CAR T-cell therapy.

What's so smart about smart bottles?

Pharmacists have an important role in screening for behavioral health disorders in patients with high-risk conditions, including diabetes.

Researchers identified a primary mechanism of inflammatory demyelination in the central nervous system during multiple sclerosis, which may lead to new therapeutic approaches.

Top news of the day from across the health care landscape

Patients with rare diseases often face a difficult and long diagnosis and treatment process.

Top news of the day from across the health care landscape

Both negative and positive outcomes have been observed in studies.

An extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae (K pneumoniae) that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.

The FDA has approved the CustomFlex Artificial Iris, the first stand-alone prosthetic iris available in the United States.

Researchers aimed to assess the relationship between fatigue in multiple sclerosis and inflammatory or other immunomediated markers.

FDA officials have approved the first generic versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy's Laboratories SA) sublingual film to treat opioid dependence.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape